The dandruff is caused by excessive desquamation of the scalp, most often associated with an imbalance in the skin flora, notably by an overgrowth of yeasts of the genus Malassezia, and to a more or less marked local inflammation. Management relies on the use of active compounds with keratolytic properties, such as salicylic acid, which facilitate the removal of scales, and antifungal compounds, such as piroctone olamine or ciclopirox olamine, aiming to normalise the populations of Malassezia.
Panthenol cannot strictly be regarded as an anti-dandruff agent, since it exhibits neither antifungal activity nor a keratolytic effect.
Conversely, its hydrating, soothing and reparative properties make it a valuable ingredient to incorporate into anti-dandruff formulations. Pro-vitamin B5 can indeed contribute to improving the tolerability of anti-dandruff treatments and to limiting the itching sensations that can accompany dandruff.
This approach is illustrated by a clinical study conducted with 20 patients presenting a seborrhoeic dermatitis of the scalp ranging from moderate to severe. Participants were treated for four weeks with a care regimen combining keratolytic and antifungal actives (salicylic acid, piroctone olamine, zinc PCA), supplemented by moisturising and soothing agents, including panthenol. The results showed a significant reduction in dandruff, itching and redness as early as the fourth week, with an overall clinical improvement observed in 80% of the patients. Furthermore, the treatment was well tolerated and no adverse effects were reported, likely in part due to panthenol.